The Customer
A leading UK-based health and wellness company with a global footprint across 100+ countries and a dominant presence in women's health, bone & joint care, and multivitamin segments. With a legacy of clinical credibility and product innovation, the company is a frontrunner in life-stage targeted supplementation, seeking private equity backing to accelerate its next phase of digital-first global expansion.
The Challenges
1. Fragmented Market Intelligence Across Segments
Despite a strong portfolio, the company operated in diverse product categories—prenatal care, menopause support, joint health, and immunity—without a consolidated view of competition or emerging consumer behavior in each vertical.
2. Inconsistent Regional Competitor Mapping
The Indian subcontinent, a key growth region, featured a fragmented competitive landscape with localized D2C brands, herbal players, and pharma-backed legacy products. Understanding this ecosystem in relation to pricing, positioning, and customer trust was critical.
3. Evolving Regulatory and Pricing Environment
Upcoming changes in India’s nutraceutical and supplement regulation—such as FSSAI enforcement, labelling norms, and price controls—posed potential risks to the company’s premium positioning and required scenario planning.
The Solution
Our team deployed a three-phase intelligence framework:
Competitive Landscape Modelling
Built a comprehensive benchmarking grid across women’s health, bone/joint care, and multivitamins, classifying over 30 regional and global competitors by:
Product-Category Deconstruction
Mapped category-specific demand signals such as:
Each product line was cross-validated with market use-cases and ingredient-level positioning.
Regulatory Risk & Opportunity Scanning
Assessed evolving FSSAI, nutraceutical labelling, and clinical claim restrictions:
Key Features Delivered
|
Feature |
Details |
|
Category Intelligence Map |
Structured taxonomy of all women's wellness, bone/joint, and multivitamin SKUs across 3 pricing tiers: mass, mid-premium, and clinical |
|
Competitor Heatmap |
Side-by-side comparison of 20+ competitors across brand visibility, channel penetration, ingredient innovation, and pricing |
|
Regulatory Tracker |
Scenario planning for policy shifts in India and high-growth export markets; impact on claims, labels, and cross-border DTC strategy |
|
Investor-Ready Narrative |
Synthesized product strength, market gaps, and brand credibility into a cohesive story for financial diligence and investor decks |
Outcomes
Enabled investors to visualize the strategic moat in key segments like prenatal care and bone density supplements
Quantified competitive threats from D2C startups and herbal entrants in India
Equipped the brand with a market-ready dossier to navigate valuation, regulatory risk, and channel expansion
Results